Streptococcus salivarius K12 and Reduced Upper Respiratory Tract Infection Severity

• Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial.

  • 2024-10-26
  • RCT · n = 112
  • Microorganisms 12(11)
  • • Alexander Bertuccioli
    • Marco Cardinali
    • Matteo Micucci
    • Marco Bruno Luigi Rocchi
    • Chiara Maria Palazzi
    • Giordano Bruno Zonzini
    • Giosuè Annibalini
    • Annalisa Belli
    • Davide Sisti

  • PubMed: 39597553
  • DOI: 10.3390/microorganisms12112164

  5 Insights on

  • Reduced Upper Respiratory Tract Infection Severity

  • High evidence

  Although the overall severity of symptoms did not differ significantly between the treatment and control groups

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  daily dose